Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

10
Number of overlapping holdings
35.7%
% of MEDX's 28 holdings also in PJP
34.5%
% of PJP's 29 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in MEDX |
Weight in PJP |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 17.1% | 5.5% | 5.5% | |
AMGEN INC | 6.1% | 5.1% | 5.1% | |
ABBVIE INC | 9.1% | 5.0% | 5.0% | |
JOHNSON & JOHNSON | 4.9% | 5.0% | 4.9% | |
PFIZER INC | 3.9% | 5.1% | 3.9% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to PJP
ELI LILLY & CO | 11.5% | |
NOVARTIS AG-ADR | 7.1% | |
ASTRAZENECA PLC-SPONS ADR | 5.8% | |
ALNYLAM PHARMACEUTICALS INC | 5.5% | |
ALKERMES PLC | 4.3% | |
ABBVIE INC | 4.1% | |
GLAXOSMITHKLINE PLC-SPON ADR | 2.9% | |
IONIS PHARMACEUTICALS, INC. | 2.8% | |
CRISPR THERAPEUTICS AG | 2.7% | |
BRISTOL-MYERS SQUIBB CO | 2.7% |
MEDX Underweight Relative to PJP
ABBOTT LABORATORIES | -5.0% | |
GILEAD SCIENCES INC | -4.9% | |
OCULAR THERAPEUTIX INC | -3.3% | |
INNOVIVA, INC. | -3.0% | |
LIGAND PHARMACEUTICALS-CL B | -2.9% | |
BIOSANTE PHARMACEUTICALS INC | -2.9% | |
AMNEAL PHARMACEUTICALS, INC. CLASS A | -2.8% | |
AMPHASTAR PHARMACEUTICALS INC | -2.7% | |
JAZZ PHARMACEUTICALS PLC | -2.6% | |
COLLEGIUM PHARMACEUTICAL, INC. | -2.6% |